Baotou Dongbao Bio-Tech Co.,Ltd
SHZ: 300239.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Fang Liu
- Employees
- 1,441
- Headquarters
- Baotou, China
- IPO year
- 2011
- Market cap
- CN¥3.3B
- Website
- https://www.dongbaoshengwu.com
Loading 300239…
Loading profile data…Frequently asked questions about 300239
What does Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) do?
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, production, and sale of gelatin and collagen products in the People's Republic of China and internationally. It offers food additive and pharmaceutical gelatin, as well as collagen peptide. The company was founded in 1997 and is based in Baotou, the People's Republic of C...
Where does 300239.SZ trade?
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300239.SZ in?
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Baotou Dongbao Bio-Tech Co.,Ltd?
Fang Liu is the chief executive officer of Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ).
Where is Baotou Dongbao Bio-Tech Co.,Ltd headquartered?
Baotou Dongbao Bio-Tech Co.,Ltd is headquartered in China.
Does 300239.SZ pay a dividend?
Yes — Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300239.SZ go public?
Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) completed its initial public offering in 2011.